Серофер 100 мг/5 мл раствор для внутривенного введения

Land: Kirgisistan

Sprog: russisk

Kilde: Правительства Кыргызской Республики (Департамент лекарственного обеспечения и медицинской техники)

Aktiv bestanddel:

Железа (III) гидроксид сахарозный комплекс

Tilgængelig fra:

Maiva Pharma Pvt Ltd (Maiva Pharma Pvt Ltd)

ATC-kode:

B03AC

INN (International Name):

Iron (III) hydroxide sucrose complex

Dosering:

100 мг/5 мл

Lægemiddelform:

раствор для внутривенного введения

Enheder i pakken:

5 мл №5

Recept type:

по рецепту

Fremstillet af:

Maiva Pharma Pvt Ltd (Индия)

Produkt oversigt:

ПЖВЛС: нет

Autorisation dato:

2019-12-13

Produktets egenskaber

vTBEPXAAK)
,^-^^-:::'jffih,
.(enaprauenrffi
o6ecneqerurfl
l,I
MeArruuscxofit
rexHIrKl'I
Munucrepcrpa
Kuprurcrcoi
fixaurcopososa
M.K
,@r-*v'
IIH
C
T
PyKII1tl
IIO
MEAI,IqI,IH
C
K
O
My
II
PIIMEHE
HIIIO
JIE
KA
CPEACTBA
CEPOOEP
'.foprroaoe
Ha3BaHrre
rperapara:
CepoSep
MexAynapog4oe
HerIareHToBaHHoe
HaIrMeHoBaHrIe:
Her
Jlerapcmenn{r
Qoppra
:
pacrBop
An,
BHyrpI'IBeHHoro
BB9A9HI'L
Cocran:
KaxlsIfi
MJI
Ilpenapara
coAePxI'IT:
n.
rrrere?a
I'IIT\
rprnn
'----
KoMlJIeKc
-
20
ur
oKntul
H
o
e
e e
ryl
c
me o
:
xeJle3a
(III)
ruapoKcllA
caxapossrrfi
6
C
n
O
M
O
2
Am
e
n Alro'
e
B
et4
e
c
m6
a
:
Harptrfl,
rr'rApoKcr,rA,
BoAa
Ans
raHrexu14fl.
Onucauue:
o$topolttafl
KopuqHeBUI
x]IAKocrb
(Dapuarorepfnenruuecrar
rpymra:
Cruuylaropbl
reMolloosa.
flpenaparbl
xeJle3a.
Ilpenapatu
Nefnesa
AJUI
IlapeurepaJlbuoro
rpllMeHeHlrfl
.
Koa
ATX:
B0trAC
O
a
pu
arolorlr
qecKlre
cn
ofi
crna
0apmaxodunlnuxa
B
rponoron,
{araro
cBr3brBaerc,
c
rpaHc$eppranorra,
B
rKaHf,x
xpaHl'Irc,
B
BrIAe
tpepputraua,
n
*o.rroo,
,oa.]a
BKrroqaerc,
B
reMorrlo6utt
lI
rcnoJlb3yerc{
B
flpoqecce
gpl{Tporlossa.
I4s
opr
aH[r3Ma
nu$o.4arcr
Jrr,rrrrb
ue6otrruue
KoruqecTBa
xeJle3a.
B
,*uo
norirrarruax
Heil3Mesensrrfi
KoMTIJIeKc
Moxer
npoxoAl'ITb
qepe3
nnaqenrapnuft
6aoreo
,
,arrhrrreJrbuoe
ero
Korr,rt{ecrBo
IronaAaer
B
rpyAHoe
MoJIoKo.
Xeneso,
cBr3aHHoe
c
Qeppurr.rno*
fnry
rpancQeppl,IHoM,
MoxeT
rpoxoAllTb
qep6
rnalleHrapusIfi
6aprep,
a
B
Coaiarr
laxrofoeppuHa,
ro[aAaer
B
rpyAHoe
MoJroKo
n
ne6onruux
Korl{rlecrBax.
(DannaxoxuHemuKa
np,
"ryrpr!.rro,
BBoAeHI,IT
rperapara
Cepo$ep
repl{oA
roryBbIBeAeHI'Is
[perapara
cocraBnrrer
6
uacor,
o6uufi
Krrr{peHc
1.2
llqac.
Tar
rax
llcqe3HoBeHl{e
xeJle3a
I'I3
[JIa3MbI
3aBr,rcr,rr
or
nbrpe6uocrr{
opraHr,BMa
B
xeJle3e,
3auacoB
xeJle3a
u
}rcIIoJIL3oBaHrIfl
xeJle3a
TKaHrMr,r
op.r[rrsra,
[JrrBMeHHufi
unpeuc
xeile3a
6yaer
6onee
6rtctpslru
y
[aII[eHToB
c
AetbnUnrorr,r
,{araau
no
cpaBHeHHIo
c
3AopoBbIMI'I
[aU]IeHTaMn.
3$Qerr
B
3aBI'IcI'IMocrI'I
or
Bo3pacra
u
no{ra
se
6ru
r3yqeH.
IloxaraHufl
K
rIp[MeHeHIrIo
Xeresolesnq[rrnue
cocrolrHr.rfl:
rrpl,t
neo6xoAlalr